Jeffrey Alan Hawkins Sells 83,712 Shares of Quantum-Si (NASDAQ:QSI) Stock

Quantum-Si Incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 83,712 shares of the business’s stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price of $1.01, for a total transaction of $84,549.12. Following the completion of the transaction, the chief executive officer directly owned 3,776,135 shares of the company’s stock, valued at approximately $3,813,896.35. This represents a 2.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Jeffrey Alan Hawkins also recently made the following trade(s):

• On Monday, March 23rd, Jeffrey Alan Hawkins sold 12,149 shares of Quantum-Si stock. The stock was sold at an average price of $0.83, for a total transaction of $10,083.67.
• On Friday, March 20th, Jeffrey Alan Hawkins sold 11,628 shares of Quantum-Si stock. The shares were sold at an average price of $0.85, for a total value of $9,883.80.

Quantum-Si Stock Down 11.3%

Shares of Quantum-Si stock opened at $0.94 on Friday. Quantum-Si Incorporated has a fifty-two week low of $0.69 and a fifty-two week high of $3.10. The business’s fifty day moving average is $0.90 and its two-hundred day moving average is $1.27. The firm has a market cap of $203.52 million, a PE ratio of -1.81 and a beta of 3.08.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.06. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%.The business had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.76 million. Equities research analysts anticipate that Quantum-Si Incorporated will post -0.5 EPS for the current year.

Analysts Set New Price Targets

QSI has been the topic of several recent analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a report on Friday, March 27th. Canaccord Genuity Group lowered their target price on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, March 4th. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Quantum-Si presently has an average rating of “Hold” and an average target price of $3.25.

Institutional Investors Weigh In On Quantum-Si

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Prudential Financial Inc. acquired a new position in shares of Quantum-Si in the 2nd quarter valued at about $25,000. Cerity Partners LLC acquired a new stake in Quantum-Si during the 2nd quarter worth approximately $29,000. Capital Investment Advisory Services LLC raised its holdings in Quantum-Si by 100.0% in the third quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock valued at $28,000 after buying an additional 10,000 shares during the period. Elite Life Management LLC purchased a new position in Quantum-Si in the third quarter valued at approximately $29,000. Finally, HBK Sorce Advisory LLC acquired a new position in Quantum-Si during the third quarter valued at approximately $30,000. 39.90% of the stock is currently owned by institutional investors and hedge funds.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.